Skip to main content

A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees

Completed · Phase 2 · NCT01925261

Conditions: Knee Osteoarthritis

At a glance

Research payments reported, 2025
$2.5M
U.S. investigators named
36
Sites paid
23
Planned or actual enrollment
120

About the trial

Sponsor
OrthoTrophix, Inc
Tested
TPX-100 50mg (drug), TPX-100 100mg (drug), TPX-100 200mg (drug), TPX-100 20mg (drug), Placebo (drug)
Dates
Started 2014-01; completion 2016-09
Results posted
Not yet

This one-year study is designed to investigate the safety and efficacy of TPX-100, a 23-amino acid chondrogenic peptide, delivered by intra-articular injection, in regeneration of knee cartilage in subjects with bilateral osteoarthritis of the knee.

From ClinicalTrials.gov, last updated 2017-04-21. Full record, eligibility and contacts (opens in a new tab)

Industry funding

American Regent reported $2.5M in research payments for this study in 2025 (34 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Biovin Enterprise LLC $488,749
  • Well Pharma Medical Research, Corp $275,572
  • Wasatch Clinical Research $169,651
  • University Orthopedics Center $142,110
  • Albuquerque Clinical Trials, Inc. $140,141
  • Erg Holding Company LLC $140,056
  • Las Mercedes Medical Research $137,841
  • K2 Medical Research LLC $123,640
  • Alliance for Multispecialty Research, LLC $123,237
  • Clinitiative $119,642
  • Noble Clinical Research, LLC $111,111
  • Jbr Clinical Research LLC $98,992
  • Marvel Clinical Research 002 LLC $93,981
  • Clinrx Research LLC $89,966
  • Texas Orthopedic Specialists, PLLC $64,377
  • University of Kansas Medical Center Research Institute, Inc. $51,195
  • Las Vegas Clinical Trials LLC $35,245
  • San Dieguito Orthopedic Medical Center $33,348
  • Phoenix Clinical Trials $30,673
  • Mayo Clinic Hospital Rochester, MN $22,660
  • The Center for Clinical Research, LLC $15,847
  • Drug Studies America $10,966
  • Accurant Clinical Management, LLC $10,955

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.